American Diabetes Association’s (ADA) 84th Scientific Sessions
Jun 23, 2024 at 1:45 PM EDT
Presentation Title: Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, in Subjects with Overweight or Obesity –A 48-Week, Placebo-Controlled, Phase 2 (MOMENTUM) Trial
Speaker: Louis Aronne, M.D., Professor of Metabolic Research and Professor of Clinical Medicine, Weil Cornell Medical School
